Breast Cancer

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection [Phase 2]

  A Phase 2 clinical trial update for anti-CMV therapy in breast cancer patients with progressive intracranial metastases and CMV infection, c…

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters) [NA]

  This is a clinical trial recruitment update from Virginia Commonwealth University focused on improving communication and adherence in Black …

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer [NA]

  A clinical trial update for a study evaluating a CIPN decision aid intended to improve chemotherapy decision-making in patients with breast …

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer [Phase 2]

  Phase 2 platform study evaluating rechallenge with antibody-drug conjugates in ADC-treated metastatic breast cancer; recruitment is ongoing.

• CLINICAL_TRIALS trial_result · 2026-04-08
  Clinical Trial Update: A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain [Phase 3]

  Phase IIIB/Phase 3 study evaluating capivasertib in combination with fulvestrant for advanced breast cancer in patients who relapsed or prog…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2026-04-07
  Clinical Trial Update: Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment [Phase 4]

  Phase 4 clinical trial update evaluating the safety of alpelisib plus fulvestrant in men and postmenopausal women with HR-positive, HER2-neg…

• CLINICAL_TRIALS trial_result · 2026-04-07
  Clinical Trial Update: Evaluation of Safety and Performance of Intraoperative Detection of Light Signals During Electrosurgical Breast Cancer Resection [NA]

  This completed clinical trial evaluated the safety and performance of intraoperative light-signal detection during electrosurgical breast ca…

• CLINICAL_TRIALS trial_result · 2026-04-07
  Clinical Trial Update: A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients [NA]

  This entry reports a completed pilot study evaluating acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer patients.

• CLINICAL_TRIALS trial_result · 2026-04-07
  Clinical Trial Update: A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer [Phase 4]

  A completed Phase 4 randomized trial compares personalized follow-up strategies with guideline-based follow-up in patients with early-stage …

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer [Phase 2]

  Phase 2 clinical trial evaluating STEMVAC in combination with chemotherapy for PD-L1 negative metastatic triple-negative breast cancer, curr…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen [NA]

  This concept-verification clinical trial investigates whether hyperbaric oxygen can inhibit progression of breast cancer that has metastasiz…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Evolution of Clinical and Motivational Constructs During the Physical Activity Program KHEOPS, Already Offered to Patients at the Centre Léon Bérard

  A clinical trial evaluating how clinical and motivational factors change during the KHEOPS physical activity program for breast cancer patie…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]

  Phase I study of SYS6043 in patients with advanced or metastatic solid tumors is currently recruiting, including prostate cancer, small cell…

• CLINICAL_TRIALS trial_result · 2026-04-07
  Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer [Phase 3]

  A Phase 3 study evaluating romiplostim for chemotherapy-induced thrombocytopenia in adults with non-small cell lung cancer, ovarian cancer, …

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

  The update describes a follow-up study of subjects previously enrolled in poxviral vector gene transfer trials, with recruitment currently o…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Breast Cancer Screening Decision Aid [NA]

  Yale University is conducting a clinical trial to evaluate a breast cancer screening decision aid; the study is currently not yet recruiting…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors [NA]

  This update covers a clinical study (NCT01450020) evaluating peer navigator education to improve survivorship care among African American br…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects [NA]

  A study evaluating photoacoustic imaging of the breast in women with breast cancer and in healthy subjects is currently recruiting.

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  A clinical trial is enrolling people with and without cancer to collect blood samples and evaluate tests for early cancer detection across m…

• CLINICAL_TRIALS trial_result · 2026-04-07
  Clinical Trial Update: Risk Communication Within Mexican-American Families

  This update summarizes a completed NHGRI-funded clinical trial that examined risk communication within Mexican-American families, with relev…

• CLINICAL_TRIALS other · 2026-04-07
  Clinical Trial Update: Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) [Phase 2]

  Phase II trial evaluating GM1 ganglioside to reduce or prevent paclitaxel-induced peripheral neuropathy in metastatic breast cancer has been…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)

  An ongoing prospective registry study enrolling patients with unresectable locally advanced or metastatic breast cancer.

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Impact of the ARM Technique on the Prevention of Lymphedema After Axillary Lymphadenectomy: A Multicenter Randomized Clinical Trial [NA]

  A multicenter randomized trial evaluating the ARM technique to prevent lymphedema after axillary lymphadenectomy in breast cancer patients. …

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. [Phase 3]

  Phase 3 clinical trial evaluating Bria-IMT Regimen and a checkpoint inhibitor versus physician's choice in advanced metastatic breast cancer…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab [Phase 3]

  Phase 3 trial update evaluating 12 months versus 6 months of HER2-targeted therapy for HER2-positive breast cancer patients who achieved pat…